Market Watch: Goldman These Nothing in Focus as New Reports Land

Goldman Sachs is steering investors toward a straightforward idea: if the artificial-intelligence trade looks crowded, consider stocks whose fortunes are less tied to it. In the latest report, the bank pointed to companies it sees as having relatively little to do with the AI boom, with Eli Lilly and Fortinet cited as examples.

The broader message is not necessarily that investors should abandon AI, but that portfolios heavily concentrated in one market narrative may benefit from names driven by different forces.

That advice lands at a moment when AI has become one of the market’s dominant themes, shaping valuations, capital flows and day-to-day sentiment across much of the equity market.

When a single story commands that much attention, investors often start searching for companies whose earnings outlooks can stand on their own rather than rise and fall with enthusiasm for the same trade.

In that sense, Goldman’s screen appears aimed less at finding “anti-AI” stocks than at identifying businesses whose performance may be governed more by company-specific fundamentals.

The two names mentioned underscore that point. Eli Lilly is rooted in healthcare, where drug development, product demand and regulatory milestones can matter far more than swings in technology momentum.

Fortinet, while still a technology company, sits in cybersecurity, an area with its own spending cycles and competitive dynamics; that makes it a reminder that “less tied to AI” does not have to mean “outside tech” altogether.

For investors, the appeal is familiar. If too much of a portfolio is exposed to one theme, even a strong one, diversification becomes valuable not because the theme is broken but because concentration risk builds quietly during long rallies.

Stocks with lower correlation to AI enthusiasm can offer a different path to returns, especially if their earnings are tied to medicine pipelines, enterprise security budgets, product execution or industry-specific demand rather than a broad re-rating of anything connected to artificial intelligence.

At the same time, the call should be read with some discipline. The available account did not lay out Goldman’s full stock list, its screening methodology, the time frame used to assess correlation, or whether the bank paired the idea with fresh ratings or price targets.

That leaves the strategic takeaway clearer than the mechanics: the bank appears to be highlighting a way to stay invested in equities without adding more exposure to the market’s most crowded trade.

That nuance matters because a shift toward lower-correlation names would not automatically signal the end of AI leadership. A more plausible near-term outcome is a gradual broadening of stock selection, in which investors keep meaningful positions in AI beneficiaries while also adding companies with distinct earnings drivers.

In that environment, alternative names do not need AI-linked shares to stumble; they only need investors to reward multiple sources of growth at the same time.

There is, however, another possibility. If AI remains the market’s strongest magnet for flows and performance, companies marketed as outside that theme may struggle to command the same urgency, even if their underlying businesses remain healthy.

For now, Goldman’s message looks less like a wholesale call to rotate out of AI and more like a reminder that strong portfolios are often built on more than one story.

Published at 2026-05-25T12:01:09.500253+00:00 UTC

Related Symbols

• LLY — Eli Lilly
• FTNT — Fortinet
• Selection note: The report specifically highlights Eli Lilly and Fortinet as Goldman Sachs picks with low correlation to the AI trade; Goldman itself is just the source of the call.

References

• CNBC